Redefining the Therapeutic Landscape of IDH-Mutant Gliomas: From Molecular Mechanisms to Clinical Application of Vorasidenib
Medical Science · 30.06.2026 · 30 (172) · 1-9
DOI: 10.54905/disssi.v30i172.e109ms3916 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Science, online erschienen am 30.06.2026. Verfasst von Karolina Siemińska und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Siemińska, K., Leżańska, Z., Marcinkowska, K., Kwiatkowski, M., Sowińska, J., Paluszkiewicz, N., Pałyga, E., Cieślak, A., Demkow, S., & Bryg, S. (2026). Redefining the Therapeutic Landscape of IDH-Mutant Gliomas: From Molecular Mechanisms to Clinical Application of Vorasidenib. Medical Science, 30(172), 1-9. https://doi.org/10.54905/disssi.v30i172.e109ms3916
Vancouver
Siemińska K, Leżańska Z, Marcinkowska K, Kwiatkowski M, Sowińska J, Paluszkiewicz N, et al. Redefining the Therapeutic Landscape of IDH-Mutant Gliomas: From Molecular Mechanisms to Clinical Application of Vorasidenib. Medical Science. 2026;30(172):1-9. doi:10.54905/disssi.v30i172.e109ms3916
BibTeX
@article{Siemiska2026,
author = {Siemińska, Karolina and Leżańska, Zofia and Marcinkowska, Katarzyna and Kwiatkowski, Mateusz and Sowińska, Joanna and Paluszkiewicz, Natalia and Pałyga, Emil and Cieślak, Aleksandra and Demkow, Sara and Bryg, Sandra},
title = {Redefining the Therapeutic Landscape of IDH-Mutant Gliomas: From Molecular Mechanisms to Clinical Application of Vorasidenib},
journal = {Medical Science},
year = {2026},
volume = {30},
number = {172},
pages = {1--9},
doi = {10.54905/disssi.v30i172.e109ms3916}
}
EUVIMED